Life Science Company News

Reset
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Altamira Therapeutics Ltd.

Novo Nordisk A/S – Reduction of the share capital

Read more ››
By: GlobeNewswire - 24 Apr 2024

Novo Nordisk A/S - Articles of Association, April 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Autonomix Medical, Inc.

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  T2 Biosystems, Inc.

Verana Health Announces Launch of Qdata® Thyroid Eye Disease

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Verana Health, Inc.

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Renovaro Inc.

Sharecare awarded three-year NCQA Accreditation for Case Management

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Sharecare, Inc.

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  HeartSciences Inc.

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Capricor Therapeutics, Inc.

Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers

Read more ››
By: GlobeNewswire - 24 Apr 2024

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Spectral AI, Inc.

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  CG Oncology, Inc.

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  ALX Oncology, Inc.

Immunocore announces upcoming presentation and posters at ASCO 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Immunocore Limited

ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferences

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Impact Biotech, LLC

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cue Biopharma, Inc.

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Coherus BioSciences, Inc.

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Werewolf Therapeutics, Inc.

Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Medicenna Therapeutics Corp.
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »